FrancophonIA/ELRC3.0 huggingface dataset:
English: This included a review of scientific literature regarding the pharmacology and toxicology of ivermectin and closantel, cumulative pharmacovigilance experience following use of the products in the EU since 2009, a comparison with ivermectin-based products and with ivermectin/closantel injectable formulations held by the MAH, investigations carried out by the MAH to identify possible factors involved in reported adverse events and proposals for risk mitigation measures and actions.
Maltese: Din inkludiet reviżjoni tal-letteratura xjentifika rigward il-farmakoloġija u ttossikoloġija ta' ivermectin u closantel, esperjenza ta' farmakoviġilanza kumulattiva wara l-użu talprodotti fl-UE sa mill-2009, tqabbil ma' prodotti bbażati fuq ivermectin u b'formulazzjonijiet injettabbli ta' ivermectin/closantel imwettaq mill-MAH, investigazzjonijiet imwettqa mill-MAH sabiex jidentifika fatturi possibbli involuti fl-avvenimenti avversi rrappurtati u proposti għal miżuri u azzjonijiet li jnaqqsu r-riskju.
English: It was also recommended that the suspension of the marketing authorisation for CLOSAMECTIN POURON SOLUTION POUR BOVINS in France be lifted.
Maltese: POUR-ON SOLUTION POUR BOVINS fi Franza.
English: The product was also recalled at veterinary clinic and wholesale level.
Maltese: Il-prodott issejjaħ lura wkoll fillivell tal-klinika veterinarja u tal-aġent.
English: The nature of the reported clinical signs was considered by ANMV to be indicative of the clinical signs associated with overdose toxicity of closantel.
Maltese: L-ANMV qieset li n-natura tas-sinjali kliniċi rrappurtati kienet indikattiva tas-sinjali kliniċi assoċjati ma' tossiċità minħabba doża eċċessiva ta' closantel.
English: The products are effective for use in beef cattle for the treatment of mixed trematode (fluke) and nematode or arthropod infestations due to roundworms, lungworms, eyeworms, warbles, mites and lice.
Maltese: Ilprodotti huma effikaċi għall-użu fil-baqar għaċ-ċanga għall-kura ta' infestazzjonijiet imħalltin ta' trematodu u nematodu jew antropodi minħabba ħniex tondi, lungworms, eyeworms, warbles, dud u qamel.
English: Between 25 May 2011 and 31 May 2015 the French medicines regulatory agency (Agence Nationale du Médicament Vétérinaire (ANMV)) received a total of 123 adverse event reports involving CLOSAMECTIN POUR-ON POUR BOVINS in which 401 animals were affected and 121 died.
Maltese: Bejn il-25 ta' Mejju 2011 u l-31 ta' Mejju 2015, l-aġenzija regolatorja tal-mediċini Franċiża (Agence Nationale du Médicament Vétérinaire (ANMV)) irċeviet total ta' 123 rapport ta' avveniment avvers li jinvolvi CLOSAMECTIN
English: The European Commission issued a decision on 22 March 2016.
Maltese: Il-Kummissjoni Ewropea ħarġet deċiżjoni fit-22 ta' Marzu 2016.
English: What is Closamectin Pour-On Solution and associated names?
Maltese: X'inhu Closamectin Pour-On Solution u ismijiet assoċjati?
English: On 8 October 2015, the European Medicines Agency (the Agency) completed a review of the animal safety of Closamectin Pour-On Solution and associated names.
Maltese: Fit-8 ta' Ottubru 2015, l-Aġenzija Ewropea għall-Mediċini (l-Aġenzija) temmet reviżjoni tas-sigurtà talannimali ta' Closamectin Pour-On Solution u ismijiet assoċjati.
English: On 19 June 2015, France triggered a procedure under Article 78 of Directive 2001/82/EC for Closamectin Pour-On Solution and associated names following evaluation of pharmacovigilance data indicating serious concerns for animal safety and subsequent suspension of the marketing authorisation for the product.
Maltese: Fid-19 ta' Ġunju 2015, Franza tat bidu għal proċedura taħt l-Artikolu 78 tad-Direttiva 2001/82/KE għal Closamectin Pour-On Solution u ismijiet assoċjati wara evalwazzjoni ta' dejta ta' farmakoviġilanza li tindika tħassib serju għas-sigurtà tal-annimali u sospensjoni sussegwenti tal-awtorizzazzjoni għattqegħid fis-suq għall-prodott.
English: Although the overall incidence of adverse events was considered to be within acceptable limits (0.006% in the last annual periodic safety update report ) the continued occurrence of serious adverse events and the severity of subsequent losses on farms in France were considered significant, which led to the suspension of the marketing authorisation in France on 6 July 2015.
Maltese: Għalkemm linċidenza globali ta' avvenimenti avversi tqieset li kienet fil-limiti aċċettabbli (0.006% fl-aħħar rapport perjodiku ta' aġġornament dwar is-sigurtà) l-okkorrenza kontinwa ta' avvenimenti avversi serji u sseverità tat-telf sussegwenti fl-irziezet fi Franza tqiesu bħala sinifikanti, u dan wassal għas-sospensjoni
English: Why were Closamectin Pour-On Solution and associated names reviewed?
Maltese: Għaliex ġew riveduti Closamectin Pour-On Solution u ismijiet assoċjati?
English: The adverse events principally related to neurological signs (ataxia, recumbency, paresis/paralysis and blindness) and/or gastrointestinal disorders (diarrhoea, anorexia etc.) some of which had a fatal outcome.
Maltese: POUR-ON POUR BOVINS fejn 401 annimal kienu affetwati u 121 mietu. Lavvenimenti avversi kienu jirrelataw b'mod prinċipali ma' sinjali newroloġiċi (atassja, rikombenza, paresi/paraliżi u telf tad-dawl) u/jew disturbi gastrointestinali (dijarea, anoressja eċċ.) fejn xi wħud minnhom kellhom riżultat fatali.
English: To investigate the potential relation between the adverse events observed and Closamectin Pour-On Solution and associated names, the CVMP considered the data provided by the marketing authorisation holder (MAH).
Maltese: Sabiex jinvestiga r-relazzjoni potenzjali bejn l-avvenimenti avversi osservati u Closamectin Pour-On Solution u ismijiet assoċjati, is-CVMP qies id-dejta pprovduta mid-detentur għall-awtorizzazzjoni għattqegħid fis-suq (MAH).
English: The Agency's Committee for Medicinal Products for Veterinary Use (CVMP) concluded that the benefits of Closamectin Pour-On Solution and associated names continue to outweigh their risks subject to variation of the marketing authorisations to include new adverse reactions and precautionary measures and conditions concerning risk mitigation and surveillance measures.
Maltese: Il-Kumitat għall-Prodotti Mediċinali għallUżu Veterinarju (CVMP) tal-Aġenzija ddeċieda li l-benefiċċji ta' Closamectin Pour-On Solution u ismijiet assoċjati jkomplu jkunu akbar mir-riskji tagħhom soġġett għall-varjazzjoni tal-awtorizzazzjonijiet għattqegħid fis-suq sabiex jinkludu reazzjonijiet avversi ġodda u miżuri u kundizzjonijiet ta' prekawzjoni rigward il-mitigazzjoni tar-riskju u l-miżuri ta' sorveljanza.
English: in and blisters (exanthemous pustulosis).
Maltese: tingħata maqsuma fi tliet dożi.
English: • inflammation of the liver (
Maltese: • żieda f'xi sustanzi (
English: {Name and address} <{Tel}> <{Fax}> <{e-mail}>
Maltese: [Isem u indirizz] <{telefon}> <{fax}> <{e-mail}>
English: <{Tel}> <{Fax}> <{e-mail}>
Maltese: {Isem u indirizz} <{telefon}> <{fax}> <{e-mail}>
English: Formulation
Maltese: Formulazzjoni
English: • diarrhoea (in adults).
Maltese: • dijarea (fl-adulti).
English: Susceptibility Breakpoints (g/ml)
Maltese: Breakpoints ta' Suxxettibilità (g/ml)
English: • collapse.
Maltese: • kollass.
English: Morganella morganii Providencia spp.
Maltese: Morganella morganii Spp.
English: Spain - Augmentine Intravenoso
Maltese: Spanja - Augmentine Intravenoso
English: Adults and adolescents  16 years
Maltese: Adulti u adoloxxenti  16-il sena
English: Advice/medical education
Maltese: Parir/edukazzjoni medika
English: Do not take Augmentin:
Maltese: Tiħux Augmentin:
English: Spain - Augmentine, Clavumox
Maltese: Spanja - Augmentine, Clavumox
English: Anaerobic micro-organisms Bacteroides fragilis Fusobacterium nucleatum Prevotella spp.
Maltese: Mikroorganiżmi anaerobiċi Bacteroides fragilis Fusobacterium nucleatum Spp.
English: • 2 tablets two times a day, for 7 to 10 days.
Maltese: • 2 pilloli darbtejn kuljum, għal bejn 7 u 10 ijiem.
English: AUC (0-) (ug.h/ml)
Maltese: AUC (0-) (ug.siegħa /ml)
English: Other micro-organisms
Maltese: Mikroorganiżmi oħra
English: [T
Maltese: [B
English: Serratia sp. Stenotrophomonas maltophilia
Maltese: Serratia Stenotrophomonas maltophilia
English: • Gastrointestinal tract
Maltese: • L-apparat gastrointestinali
English: Adults and children  40 kg:
Maltese: Adulti u tfal  40 kg:
English: Aerobic Gram-negative micro-organisms Haemophilus influenzae2
Maltese: Mikroorganiżmi Gram-negattivi aerobiċi Haemophilus influenzae2
English: Crystalluria9
Maltese: Kristallurja9
English: Crystalluria8
Maltese: Kristallurja8
English: Enterobacter sp.
Maltese: Sp.Enterobacter
English: Reversible hyperactivity
Maltese: Attività eċċessiva riversibbli
English: Germany - Augmentan IV
Maltese: Il-Ġermanja - Augmentan IV
English: • Pyelonephritis
Maltese: • Pajelonefrite
English: Denmark - Spektraforte
Maltese: Id-Danimarka -Spektraforte
English: Romania - Augmentin Intravenos Spain - Augmentine Intravenoso
Maltese: Ir-Rumanija - Augmentin Intravenos Spanja - Augmentine Intravenoso
English: Aerobic Gram-positive micro-organisms Enterococcus faecalis
Maltese: Mikroorganiżmi Gram-pożittivi aerobiċi Enterococcus faecalis
English: Aerobic Gram-negative micro-organisms Escherichia coli
Maltese: Mikroorganiżmi Gram-negattivi aerobiċi Escherichia coli
English: • Augmentin contains aspartame (E951) which is a source of phenylalanine.
Maltese: • Augmentin fih aspartame (E951) li huwa sors ta' phenylalanine.
English: AMX - amoxicillin, CA - clavulanic acid * Median (range)
Maltese: AMX - amoxicillin, CA - clavulanic acid * Medjan (medda)
English: Cross-reactions with non-Aspergillus polysaccharides and polyfuranoses with Bio-Rad Laboratories Platelia Aspergillus EIA test have been reported.
Maltese: Cross-reactions ma' polysaccharides u polyfuranoses li mhumiex ta' Aspergillus ġew irrappurtati bit-test ta' Bio-Rad Laboratories Platelia għal Aspergillus.
English: • Augmentin contains maltodextrin (glucose).
Maltese: • Augmentin fih maltodextrin (glucose).
English: Common (1/100 to <1/10)
Maltese: Komuni(1/100 sa <1/10)
English: Other micro-organisms Chlamydia trachomatis Chlamydophila pneumoniae Chlamydophila psittaci Coxiella burnetti Mycoplasma pneumoniae
Maltese: Mikroorganiżmi oħra Chlamydia trachomatis Chlamydophila pneumoniae Chlamydophila psittaci Coxiella burnetti Mycoplasma pneumoniae
English: Vascular disorders Thrombophlebitis3
Maltese: Disturbi vaskulari Tromboflebite3
English: Final volume of reconstituted oral suspension (ml)
Maltese: Volum finali tas-suspensjoni orali rikostitwita (ml))
English: ND − Not determined * Median (range) ^ for an MIC of 4 mg/l
Maltese: ND − Mhux iddeterminat * Medjan (medda) ^ għal MIC ta' 4 mg/l
English: • dizziness • headache.
Maltese: • uġigħ ta' ras.
English: Mycoplasma pneumoniae $ Natural intermediate susceptibility in the absence of acquired mechanism of resistance.
Maltese: Mycoplasma pneumoniae $ Suxxettibilità intermedja naturali fin-nuqqas ta' mekkaniżmi ta' reżistenza akkwiżiti.
English: • Inactivation by those bacterial beta-lactamases that are not themselves inhibited by clavulanic acid, including class B, C and D.
Maltese: • L-inattivazzjoni permezz ta' dawk il-beta-lactamases batteriċi li huma stess ma jiġux impediti minn clavulanic acid, inkluż il-klassijiet B, C u D.
English: Ireland - Augmentin Duo
Maltese: L-Irlanda - Augmentin Duo
English: Inherently resistant organisms Aerobic Gram-negative micro-organisms Legionella pneumophila
Maltese: Organiżmi reżistenti b'mod inerenti Mikroorganiżmi Gram-negattivi aerobiċi Legionella pneumophila
English: 1000 mg/200 mg every 8 hours.
Maltese: 1000 mg/200 mg kull 8 sigħat.
English: (this is a minimum volume).
Maltese: (dan huwa volum minimu).
English: • standard dose (for all indications): 1000 mg/125 mg three times a day;
Maltese: • doża standard (għall-indikazzjonijiet kollha): 1000 mg/125 mg tliet darbiet kuljum;
English: n this leaflet:
Maltese: Dożi rrakkomandati:
English: Po a rtug l - Augmentin Duo, Clavamox DT Ro i man a - Augmentin BIS
Maltese: Jekk m'intix ċert/a, kellem lit-tabib jew lill-ispiżjar tagħhom qabel ma tagħti Augmentin.
English: T1/2 (h)
Maltese: T1/2 (siegħa)
English: Sw n ede - Spektramox
Maltese: L-Isvezja - Spektramox
English: Germany - Augmentan
Maltese: Spanja - Augmentine
English: Adults and children  40 kg
Maltese: Adulti u tfal  40 kg
English: Hepatitis4
Maltese: Epatite4
English: Oral anticoagulants and penicillin antibiotics have been widely used in practice without reports of interaction.
Maltese: Antikoagulanti orali u antibijotiċi tal-penicillin ġew użati ħafna fil-prattika mingħajr rapporti ta' interazzjoni.
English: Romania - Augmentin Intravenos Slovenia - Augmentin Spain - Augmentine Intravenoso United Kingdom - Augmentin Intravenous
Maltese: Ir-Rumanija - Augmentin Intravenos Slovenja - Augmentin Spanja - Augmentine Intravenoso Ir-Renju Unit - Augmentin Intravenous
English: History of jaundice/hepatic impairment due to amoxicillin/clavulanic acid (see section 4.8).
Maltese: Storja ta' suffejra/indeboliment tal-fwied minħabba amoxicillin/clavulanic acid (ara sezzjoni 4.8).
English: Other micro-organisms Chlamydophila pneumoniae Chlamydophila psittaci Coxiella burnetti Mycoplasma pneumoniae
Maltese: Mikroorganiżmi oħra Chlamydophila pneumoniae Chlamydophila psittaci Coxiella burnetti Mycoplasma pneumoniae
English: Ba to
Maltese: Tista'
English: 8 See section 4.9
Maltese: 8Ara sezzjoni 4.9
English: T>MIC^ h (%)
Maltese: T>MIC^ siegħa
English: Hepatitis7
Maltese: Epatite7
English: Children < 40 kg
Maltese: Tfal < 40 kg
English: Symptoms and signs of overdose
Maltese: Sintomi u sinjali ta' doża eċċessiva
English: Aerobic Gram-negative micro-organisms Actinobacillus actinomycetemcomitans Capnocytophaga spp.
Maltese: Mikroorganiżmi Gram-negattivi aerobiċi Actinobacillus actinomycetemcomitans Spp. Capnocytophaga Eikenella corrodens
English: Ireland - Augmentin Duo, Augmentin Latvia - Augmentin
Maltese: L-Irlanda - Augmentin Duo, Augmentin Il-Latvja - Augmentin
English: In this leaflet:
Maltese: Doża rrakkomadata:
English: About 25% of total plasma clavulanic acid and 18% of total plasma amoxicillin is bound to protein.
Maltese: Madwar 25% tat-total ta' clavulanic acid fil-plażma u 18% tat-total ta' amoxicillin fil-plażma huwa mwaħħal mal-proteini.
English: Hungary - Augmentin, Augmentin Duo Iceland - Augmentin
Maltese: L-Ungerija - Augmentin, Augmentin Duo L-Islanda - Augmentin
English: Gram-negative Anaerobes1 Gram-positive Anaerobes1
Maltese: Anaerobi Gram-negattivi1 Anaerobi Gram-pożittivi1
English: • hyperactivity
Maltese: • attività eċċessiva
English: The usual doses are:
Maltese: • doża standard:
English: names:
Maltese: ISEM
English: [See Annex I - To be completed nationally] Amoxicillin/clavulanic acid
Maltese: [Ara Anness I - Biex timtela mill-pajjiż partikolari] Amoxicillin/clavulanic acid
English: • lung infections.
Maltese: • infezzjonijiet fil-pulmun.
English: Italy - Augmentin, Neoduplamox, Clavulin Latvia - Augmentin
Maltese: L-Italja - Augmentin, Neoduplamox, Clavulin Il-Latvja - Augmentin
English: 875 mg/125 mg powder for oral suspension in sachets Italy - Augmentin, Neoduplamox, Clavulin Spain - Augmentine, Clavumox
Maltese: Trab ta' 875 mg/125 mg fi qratas għal suspensjoni orali L-Italja - Augmentin, Neoduplamox, Clavulin Spanja - Augmentine, Clavumox
English: Hepatitis6
Maltese: Epatite6
English: • crystals in urine.
Maltese: • kristalli fl-awrina.
English: This medicinal product contains 29.3 mg (1.3 mmol) of sodium per tablet.
Maltese: Dan il-prodott mediċinali fih 29.3 mg (1.3 mmol) ta' sodium f'kull pillola.
English: Augmentin sustained release formulation has a unique PK/PD profile.
Maltese: Il-formulazzjoni li terħi l-mediċina bil-mod ta'Augmentin għandha profil PK/PD uniku.
English: Portugal - Augmentin, Clavamox, Noprilam, Penilan Spain - Clavumox
Maltese: Il-Portugall - Augmentin, Clavamox, Noprilam, Penilan Spanja - Clavumox
English: For surgical prophylaxis
Maltese: Għal profilassi kirurġika
English: Augmentin dosed at
Maltese: Tkomplix tieħu Augmentin.
English: • Augmentin 500 mg/50 mg contains approximately 9.8 mg (0.3 mmol) of potassium.
Maltese: • Augmentin 500 mg/50 mg fih madwar 9.8 mg (0.3 mmol) ta' potassium.
English: T 1/2 (h)
Maltese: T 1/2 (siegħa)
English: • low number of cells inv low number of white blo ther side effects Other side effects have occurred in a very sm
Maltese: • numru baxx ta' ċellu Effetti sekondarji oħra Effetti seko magħrufa.
English: 11 See section 4.3 and 4.4
Maltese: 11 Ara sezzjoni 4.3 u 4.4
English: Penicillins may reduce the excretion of methotrexate causing a potential increase in toxicity.
Maltese: Il-penicillins jistgħu jnaqqsu t-tneħħija ta' methotrexate u jikkawżaw possibiltà ta' żieda fit-tossiċità.
English: Portugal - Augmentin Duo, Clavamox DT, Noprilam DT, Penilan DT Romania - Augmentin
Maltese: Il-Portugall- Augmentin Duo, Clavamox DT, Noprilam DT, Penilan DT Ir-Rumanija - Augmentin
English: Prior to haemodialysis 15 mg/3.75 mg/kg.
Maltese: Dijalisi tad-demm 15 mg/3.75 mg/kg kuljum darba kuljum.
English: In such patients, Augmentin formulations with an amoxicillin to clavulanic acid ratio of 5:1 are recommended.
Maltese: F'pazjenti bħal dawn, formulazzjonijiet ta' Augmentin b'amoxicillin u clavulanic acid fi proporzjon ta' 5:1 huma rrakkomandati.
English: Ta th
Maltese: AKTAR TAG
English: 2 See section 4.4.
Maltese: 2 Ara sezzjoni 4.4.
English: Acute generalised exanthemous pustulosis (AGEP)10
Maltese: Pustulożi Eksantematuża Akuta Mifruxa (AGEP)10
English: Following oral administration, amoxicillin and clavulanic acid are approximately 70% bioavailable.
Maltese: Wara għotimill-ħalq, amoxicillin u clavulanic acid huma disponibbli madwar 70%.
English: Pseudomonas sp.
Maltese: Pseudomonas
English: 600 mg/42.9 mg/5 ml powder for oral suspension Bulgaria - Augmentin ES Cyprus - Augmentin ES
Maltese: Trab għal suspensjoni orali ta' 600 mg/42.9 mg/5 ml Il-Bulgarija - Augmentin ES Ċipru - Augmentin ES
English: Blood and lymphatic system disorders Reversible leucopenia (including neutropenia)
Maltese: Disturbi tad-demm u tas-sistema limfatika Lewkopenija riversibbli (inkluż newtropenija)
English: Streptococcus pyogenes and other beta-haemolytic streptococci Streptococcus viridans group
Maltese: Streptococcus pyogenes u streptococci beta-emolitiċi oħra Grupp Streptococcus viridans
English: Amoxicillin is a semisynthetic penicillin (beta-lactam antibiotic) that inhibits one or more enzymes (often referred to as penicillin-binding proteins, PBPs) in the biosynthetic pathway of bacterial peptidoglycan, which is an integral structural component of the bacterial cell wall.
Maltese: Amoxicillin huwa penicillin semisintetiku (antibijotiku beta-lactam) li jimpedixxi enzima waħda jew aktar (ħafna drabi magħrufa bħala proteini li jeħlu mal-penicillin, PBPs) fir-rotta bijosintetika talpeptidoglycan tal-batterji, li huwa komponent strutturali integrali tas-superfiċje taċ-ċellula tal-batterji.
English: 500 mg/125 mg, 875/125 mg, 500 mg/62.5 mg film-coated tablets
Maltese: Pilloli ta' 500 mg/125 mg, 875/125 mg, 500 mg/62.5 mg miksijin b'rita
English: 15 mg/3.75 mg/kg as a single daily dose (maximum 500 mg/125 mg).
Maltese: 15 mg/3.75 mg/kg bħala doża waħda kuljum (massimu 500 mg/125 mg).
English: This medicinal product contains maltodextrin (glucose).
Maltese: Dan il-prodott mediċinali fih maltodextrin (glucose).
English: $ Natural intermediate susceptibility in the absence of acquired mechanism of resistance.
Maltese: $ Suxxettibilità intermedja naturali fin-nuqqas ta' mekkaniżmi ta' reżistenza akkwiżiti.
English: • Cellulitis
Maltese: • Ċellulite
English: Species for which acquired resistance may be a problem Aerobic Gram-positive micro-organisms Enterococcus faecium $
Maltese: Speċi li għalihom reżiztenza akkwiżita tista' tkun problema Mikroorganiżmi Gram-pożittivi aerobiċi Enterococcus faecium $
English: • Augmentin 2000 mg/200 mg contains approximately 39.3 mg (1.0 mmol) of potassium.
Maltese: • Augmentin 2000 mg/200 mg fih madwar 39.3 mg (1.0 mmol) ta' potassium.
English: Acute generalised exanthemous pustulosis (AGEP)9
Maltese: Pustulożi Eksantematuża Akuta Mifruxa (AGEP)9
English: • Augmentin 500 mg/100 mg contains approximately 31.4 mg (1.4 mmol) of sodium.
Maltese: • Augmentin 500 mg/100 mg fih madwar 31.4 mg (1.4 mmol) ta' sodium.
English: Netherlands - Augmentin, Amoxicilline/clavulaanzuur Poland - Augmentin
Maltese: L-Olanda - Augmentin, Amoxicilline/clavulaanzuur Il-Polonja - Augmentin
English: Urinary recovery (%, 0 to 6 h )
Maltese: Sejba mill-ġdid flawrina (%, 0 sa 6 sigħat)
English: • Augmentin 500 mg/50 mg contains approximately 31.5 mg (1.4 mmol) of sodium.
Maltese: • Augmentin 500 mg/50 mg fih madwar 31.5 mg (1.4 mmol) ta' sodium.
English: 125 mg/62.5 mg/5 ml powder for oral suspension This medicinal product contains maltodextrin (glucose).
Maltese: Trab għal suspensjoni orali ta' 125 mg/62.5 mg/5 ml Dan il-prodott mediċinali fih maltodextrin (glucose).
English: Allergic reactions:
Maltese: Reazzjonijiet allerġiċi:
English: France - Augmentin IV
Maltese: Franza - Augmentin IV
English: • Cystitis
Maltese: • Ċistite
English: CrCl: 10-30 ml/min 250 mg/125 mg twice daily CrCl < 10 ml /min
Maltese: CrCl: 10-30 ml/min 250 mg/125 mg darbtejn kuljum CrCl < 10 ml/min
English: CrCl: 10-30 ml/min 15 mg/3.75 mg/kg twice daily (maximum 500 mg/125 mg twice daily).
Maltese: Tfal < 40 kg CrCl: 10-30 ml/min 15 mg/3.75 mg/kg darbtejn kuljum (massimu 500 mg/125 mg darbtejn kuljum).
English: The apparent volume of distribution is around 0.3-0.4 l/kg for amoxicillin and around 0.2 l/kg for clavulanic acid.
Maltese: Il-volum ta' distribuzzjoni li jidher huwa madwar 0.3-0.4 l/kg għal amoxicillin u madwar 0.2 l/kg għal clavulanic acid.
English: £All methicillin-resistant staphylococci are resistant to amoxicillin/clavulanic acid 1Streptococcus pneumoniae that is fully susceptible to penicillin may be treated with this presentation of amoxicillin/clavulanic acid.
Maltese: 1Streptococcus pneumoniae li huwa kompletament suxxettibbli għal penicillin jista' jiġi kkurat b'din il-preżentazzjoni ta' amoxicillin/clavulanic acid.
English: Dose Mean peak serum conc (g/ml)
Maltese: L-ogħla konċentrazzjo ni medja fisserum (g/ml)
English: Portugal - Augmentin Forte, Clavamox, Noprilam, Penilan Forte Sweden - Spektramox
Maltese: Il-Portugall - Augmentin Forte, Clavamox, Noprilam, Penilan Forte L-Isvezja - Spektramox
English: Amoxicillin is partly excreted in the urine as the inactive penicilloic acid in quantities equivalent to up to 10 to 25% of the initial dose.
Maltese: Amoxicillin huwa parzjalment imneħħi fl-awrina bħala penicilloic acid inattiv fi kwantitajiet ekwivalenti għal bejn 10 u 25% tad-doża tal-bidu.
English: Bulgaria - Augmentin Czech Republic - Augm Denmark - Spektramox Hungary - Augment Ireland - Augmentin, Malta - Augmentin Poland - Augmentin Slovak Republic - Augmentin
Maltese: Ir-Repubblika Ċeka- Aug Id-Danimarka - Spektramox L-Ungerija - Augme L-Irlanda - Augmentin, C Malta - Augmentin Il-Polonja - Augmentin Is-Slovakkja- Augmentin
English: 125 mg/62.5 mg/5 ml powder for oral suspension Ireland - Augmentin, Clavamel
Maltese: Trab għal suspensjoni orali ta' 125 mg/62.5 mg/5 ml L-Irlanda - Augmentin, Clavamel
English: There have been reports of positive test results using the Bio-Rad Laboratories Platelia Aspergillus EIA test in patients receiving amoxicillin/clavulanic acid who were subsequently found to be free of Aspergillus infection.
Maltese: Kien hemm rapporti ta' riżultati pożittivi bl-użu tat-test ta' Bio-Rad Laboratories Platelia għal Aspergillus f'pazjenti li kienu qed jirċievu amoxicillin/clavulanic acid u li sussegwentement instabu li ma kellhomx infezzjoni b'Aspergillus.
English: History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another beta-lactam agent (e.g. a cephalosporin, carbapenem or monobactam).
Maltese: Storja ta' reazzjoni qawwija immedjata ta' sensittività eċċessiva (eż. anafilassi) għal sustanzi oħra beta-lactam (eż. cephalosporin, carbapenem jew monobactam).
English: Denmark- Spektramox
Maltese: -Isvezja - Spektramox
English: Convulsions2
Maltese: Aċċessjonijiet2
English: Staphylococcus aureus (methicillin-susceptible)£ Streptococcus agalactiae
Maltese: Staphylococcus aureus (suxxettibbli għal methicillin)£ Streptococcus agalactiae